China News Service, Shanghai, March 8 (Reporter Chen Jing) Among the many malignant tumors that seriously threaten women's life and health, ovarian cancer is known as the "king of women's cancer".
The reporter learned on the 8th that both newly diagnosed ovarian cancer patients and platinum-sensitive recurrence patients can benefit from targeted drugs-PARP inhibitors, which greatly prolong the disease progression-free survival period and bring "clinical" to many patients. Healing" hope.
Martin, an academician of the Chinese Academy of Engineering, pointed out on the same day: "Ovarian cancer has three main characteristics: late detection, easy recurrence, and high fatality rate. Easy recurrence is one of the most worrying problems for patients during treatment, and more than 70% of patients will develop symptoms within three years after treatment. Recurrence and five-year survival period are not only for patients, but also for doctors, it is also a very big challenge." Martin emphasized that ovarian cancer treatment is relatively complicated and is a long-term battle, which needs to be established while raising the awareness of standardized diagnosis and treatment. The whole course of disease management cognition can effectively improve the benefit of patients.
The expert pointed out that in recent years, with the advent of targeted therapy, ovarian cancer treatment has entered the era of precision therapy.
The occurrence of ovarian cancer has a clear relationship with the tumor suppressor gene BRCA. For the treatment of ovarian cancer patients with BRCA gene mutations, innovative targeted drugs PARP inhibitors have been widely used in clinical practice, killing cancer cells through the principle of "synthetic lethality", It rewrote the traditional chemotherapy mode and became a "new weapon" for the precise treatment of ovarian cancer.
"During the treatment process, on the one hand, patients need to strengthen self-management and maintain a positive attitude. At the same time, care and encouragement from doctors, family members, friends and even the society is also crucial, which can greatly boost the confidence and confidence of ovarian cancer patients in fighting cancer. Determined to help them cross the 5-year or even longer survival period." Academician Martin said.
The reporter learned on the same day that the "2022 China Ovarian Cancer Patient Care Project-5 Miracle" public welfare project was officially launched.
The project aims to unite public welfare foundations, authoritative experts, patient organizations, pharmaceutical companies and other forces to jointly pay attention to ovarian cancer patients, actively promote standardized treatment and precise treatment of ovarian cancer diseases, and support patients to live an active life and help more patients to overcome 5-year survival period.
Li Xiaoshi, Secretary General of Beijing Kanghua Traditional Chinese and Western Medicine Development Foundation, said: "Ovarian cancer has brought a huge burden to many female patients and their families. We hope to join hands with more efforts to help ovarian cancer patients and help them achieve high-quality, Living with dignity is what this project was all about, and that’s our vision.”
"For every ovarian cancer patient, the 5-year survival period is a big challenge, and it is conceivable that they will face some difficult times. Therefore, we hope that by connecting experts, patient organizations and caring companies, we can give them both Bring the necessary professional help and guidance, and bring them family-like warmth, fight side by side with them and face the future." Li Xiaoshi pointed out that the 2022 China Ovarian Cancer Patient Care Project regards "5 Miracles" as the entire series of care activities The theme of , will focus on helping more ovarian cancer patients across the five-year journey.
According to reports, in order to help the public face the disease with a scientific and positive attitude, the public welfare project will combine disease popularization awareness and caring for cancer patients through a variety of public welfare forms such as videos, books, and activities, and explore the personal experience of ovarian cancer patients. Send blessings to ovarian cancer patients, and encourage patients to face the disease positively and optimistically with the power of group anti-cancer, so as to achieve a better long-term survival.
(over)